5 months ago
AKRO
AnalystsMichael UlzMichael Ulz's Stock Forecasts
AnalystsMichael Ulz
Sectors:
Industries:
Analyst Ranking
Top 11%
#508 out of 4922 analysts
Average Return
+16.7%
Win Rate
51%38 out of 74
Risk vs Reward
Poor
Good
Michael Ulz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Silence Therapeutics PLCSLN | +310.96% | $5.29 | $21.74 | 2023-07-24 - 2024-07-23 | Strong Buy |
Alpine Immune Sciences IncALPN | +300.75% | $16.07 | $64.40 | 2023-11-03 - 2024-04-11 | Strong Buy |
Silence Therapeutics PLCSLN | +261.98% | $5.76 | $20.85 | 2023-06-12 - 2024-06-11 | Strong Buy |
Iveric Bio IncISEE | +255.14% | $11.19 | $39.74 | 2022-07-07 - 2023-07-06 | Strong Buy |
Silence Therapeutics PLCSLN | +254.17% | $5.87 | $20.79 | 2023-07-17 - 2024-07-16 | Strong Buy |
Michael Ulz Analyst Color
Get additional color on Michael Ulz's coverage of popular stocks
10 months ago
DYN
a year ago
THRD
a year ago
SLN
a year ago
MIRM
a year ago
ALPN
Michael Ulz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Karyopharm Therapeutics IncKPTI | 6 | Buy | $42.00 | +856.72% | Maintains | 2 months ago |
Silence Therapeutics PLCSLN | 12 | Strong Buy | $25.00 | +331.78% | Maintains | 2 months ago |
Viking Therapeutics IncVKTX | 3 | Strong Buy | $102.00 | +284.62% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 10 | Hold | $268.00 | -16.98% | Maintains | 3 months ago |
Kyverna Therapeutics IncKYTX | 2 | Strong Buy | $20.00 | +509.76% | Maintains | 3 months ago |
Cabaletta Bio IncCABA | 6 | Strong Buy | $22.00 | +1,301.27% | Maintains | 3 months ago |
Aardvark Therapeutics IncAARD | 1 | Strong Buy | $29.00 | +116.58% | Initiates Coverage On | 4 months ago |
Y Mabs Therapeutics IncYMAB | 6 | Strong Sell | $7.00 | +48.94% | Maintains | 4 months ago |
Iovance Biotherapeutics IncIOVA | 4 | Buy | $20.00 | +1,083.43% | Maintains | 4 months ago |
Third Harmonic Bio IncTHRD | 5 | Hold | $5.00 | -7.92% | Downgrades | 5 months ago |
Fractyl Health IncGUTS | 2 | Strong Buy | $10.00 | +509.76% | Maintains | 5 months ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $96.00 | +70.85% | Maintains | 5 months ago |
Dyne Therapeutics IncDYN | 2 | Strong Buy | $52.00 | +443.36% | Maintains | 10 months ago |
Blueprint Medicines CorpBPMC | 9 | Hold | $115.00 | -10.23% | Maintains | a year ago |
Mirum Pharmaceuticals IncMIRM | 3 | Strong Buy | $57.00 | N/A | Maintains | a year ago |
Arrowhead Pharmaceuticals IncARWR | 4 | Hold | $27.00 | N/A | Maintains | a year ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | a year ago |
Fate Therapeutics IncFATE | 7 | Hold | $7.00 | N/A | Maintains | a year ago |
Kalaris Therapeutics IncKLRS | 4 | Strong Sell | $11.50 | N/A | Downgrades | a year ago |
Ionis Pharmaceuticals IncIONS | 4 | Hold | $48.00 | N/A | Maintains | 2 years ago |
Oric Pharmaceuticals IncORIC | 2 | Buy | $27.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 8 | Hold | $37.00 | N/A | Maintains | 2 years ago |
Iveric Bio IncISEE | 3 | Strong Buy | $35.00 | N/A | Maintains | 2 years ago |
Senti Biosciences IncSNTI | 3 | Hold | $20.00 | N/A | Maintains | 2 years ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Xilio Therapeutics IncXLO | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Allakos IncALLK | 4 | Hold | $8.00 | N/A | Maintains | 2 years ago |
Taysha Gene Therapies IncTSHA | 1 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Vir Biotechnology IncVIR | 1 | Hold | $30.00 | N/A | Upgrades | 2 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Strong Buy | $90.00 | N/A | Maintains | 3 years ago |
Jounce Therapeutics IncJNCE | 3 | Hold | $7.00 | N/A | Downgrades | 3 years ago |
Tectonic Therapeutic IncTECX | 2 | Hold | $36.00 | N/A | Maintains | 3 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $38.00 | N/A | Downgrades | 4 years ago |
Iteos Therapeutics IncITOS | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 5 years ago |
Neurogene IncNGNE | 1 | Buy | $125.00 | N/A | Initiates Coverage On | 5 years ago |
Atreca IncBCEL | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Merrimack Pharmaceuticals IncMACK | 2 | Hold | $4.00 | N/A | Maintains | 7 years ago |
Aceragen IncACGN | 1 | Buy | $4.00 | N/A | Maintains | 7 years ago |
Mersana Therapeutics IncMRSN | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 7 years ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Buy | $80.00 | N/A | Maintains | 8 years ago |
Amicus Therapeutics IncFOLD | 2 | Buy | $15.00 | N/A | Maintains | 8 years ago |
Tesaro IncTSRO | 1 | Hold | $182.00 | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.